252 related articles for article (PubMed ID: 8761081)
1. [Xeroderma pigmentosum. A study in 40 Algerian patients].
Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M
Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081
[TBL] [Abstract][Full Text] [Related]
2. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
[TBL] [Abstract][Full Text] [Related]
3. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
4. High mutation frequency in ras genes of skin tumors isolated from DNA repair deficient xeroderma pigmentosum patients.
Daya-Grosjean L; Robert C; Drougard C; Suarez H; Sarasin A
Cancer Res; 1993 Apr; 53(7):1625-9. PubMed ID: 8453633
[TBL] [Abstract][Full Text] [Related]
5. The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors.
Daya-Grosjean L; Sarasin A
Mutat Res; 2005 Apr; 571(1-2):43-56. PubMed ID: 15748637
[TBL] [Abstract][Full Text] [Related]
6. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
Suarez HG; Daya-Grosjean L; Schlaifer D; Nardeux P; Renault G; Bos JL; Sarasin A
Cancer Res; 1989 Mar; 49(5):1223-8. PubMed ID: 2645047
[TBL] [Abstract][Full Text] [Related]
7. Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients.
Sato M; Nishigori C; Zghal M; Yagi T; Takebe H
Cancer Res; 1993 Jul; 53(13):2944-6. PubMed ID: 8319200
[TBL] [Abstract][Full Text] [Related]
8. Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes.
Dumaz N; Duthu A; Ehrhart JC; Drougard C; Appella E; Anderson CW; May P; Sarasin A; Daya-Grosjean L
Mol Carcinog; 1997 Dec; 20(4):340-7. PubMed ID: 9433478
[TBL] [Abstract][Full Text] [Related]
9. DNA strand bias in the repair of the p53 gene in normal human and xeroderma pigmentosum group C fibroblasts.
Evans MK; Taffe BG; Harris CC; Bohr VA
Cancer Res; 1993 Nov; 53(22):5377-81. PubMed ID: 8221675
[TBL] [Abstract][Full Text] [Related]
10. Activated oncogenes in human tumors.
Suárez HG
Anticancer Res; 1989; 9(5):1331-43. PubMed ID: 2686533
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
[TBL] [Abstract][Full Text] [Related]
12. Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.
Zeng L; Quilliet X; Chevallier-Lagente O; Eveno E; Sarasin A; Mezzina M
Gene Ther; 1997 Oct; 4(10):1077-84. PubMed ID: 9415314
[TBL] [Abstract][Full Text] [Related]
13. XPA-deficiency in hairless mice causes a shift in skin tumor types and mutational target genes after exposure to low doses of U.V.B.
de Vries A; Berg RJ; Wijnhoven S; Westerman A; Wester PW; van Kreijl CF; Capel PJ; de Gruijl FR; van Kranen HJ; van Steeg H
Oncogene; 1998 Apr; 16(17):2205-12. PubMed ID: 9619829
[TBL] [Abstract][Full Text] [Related]
14. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
15. Strand specificity and absence of hot spots for p53 mutations in ultraviolet B-induced skin tumors of XPA-deficient mice.
Takeuchi S; Nakatsu Y; Nakane H; Murai H; Hirota S; Kitamura Y; Okuyama A; Tanaka K
Cancer Res; 1998 Feb; 58(4):641-6. PubMed ID: 9485015
[TBL] [Abstract][Full Text] [Related]
16. Genetic homogeneity of mutational spectrum of group-A xeroderma pigmentosum in Tunisian patients.
Messaoud O; Ben Rekaya M; Cherif W; Talmoudi F; Boussen H; Mokhtar I; Boubaker S; Amouri A; Abdelhak S; Zghal M
Int J Dermatol; 2010 May; 49(5):544-8. PubMed ID: 20534089
[TBL] [Abstract][Full Text] [Related]
17. [Neurological manifestations and molecular basis of group A xeroderma pigmentosum].
Mimaki T; Tanaka K; Nagai A; Mino M
Nihon Rinsho; 1993 Sep; 51(9):2488-93. PubMed ID: 8105118
[TBL] [Abstract][Full Text] [Related]
18. [Neurological abnormalities in xeroderma pigmentosum].
El Fékih N; Fredj M; Aounallah-Skhiri H; Fazaa B; Zghal M; Ridha Kamoun M
Rev Neurol (Paris); 2009 Nov; 165(11):967-70. PubMed ID: 19268336
[TBL] [Abstract][Full Text] [Related]
19. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study.
Bhutto AM; Shaikh A; Nonaka S
Br J Dermatol; 2005 Mar; 152(3):545-51. PubMed ID: 15787826
[TBL] [Abstract][Full Text] [Related]
20. Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient.
Williams C; Pontén F; Ahmadian A; Ren ZP; Ling G; Rollman O; Ljung A; Jaspers NG; Uhlén M; Lundeberg J; Pontén J
Cancer Res; 1998 Jun; 58(11):2449-55. PubMed ID: 9622088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]